Funding Rounds
OptiNose

OptiNose Series C (2010, $48M)

OptiNose

Nasal drug developer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $48.50M

Raised Date: 2010-07-01

Investors